Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stijn L W Koolen

Showing results (1-10 of 125) with videos related to

Pageof 13
Sort By:
Cancers|August 12, 2022
Drug Repurposing, a Fast-Track Approach to Develop Effective Treatments for GlioblastomaIoannis Ntafoulis, Stijn L W Koolen, Sieger Leenstra, et al.
International Journal of Nanomedicine|November 2, 2020
Recent Clinical Developments of Nanomediated Drug Delivery Systems of Taxanes for the Treatment of CancerRuben A G van Eerden, Ron H J Mathijssen, Stijn L W Koolen
Drugs|March 14, 2024
Tamoxifen Dose De-Escalation: An Effective Strategy for Reducing Adverse Effects?Sanne M Buijs, Stijn L W Koolen, Ron H J Mathijssen, et al.
Cardiovascular Research|February 7, 2019
Vascular Cardio-Oncology: Vascular Endothelial Growth Factor inhibitors and hypertensionJorie Versmissen, Katrina M Mirabito Colafella, Stijn L W Koolen, et al.
Drugs|February 12, 2025
From Prospective Evaluation to Practice: Model-Informed Dose Optimization in OncologyBram C Agema, Birgit C P Koch, Ron H J Mathijssen, et al.
Pharmacology Research & Perspectives|July 26, 2024
Treatment of [99mTc]Tc-hydroxy-diphosphonate ([99mTc]Tc-HDP) extravasation using hyaluronidaseKevin R Doornhof, Quido de Lussanet de la Sablonière, Stijn L W Koolen, et al.
British Journal of Clinical Pharmacology|June 20, 2023
Pharmacokinetic profile of irinotecan in patients with chronic kidney disease: Two cases and literature reviewChang Yue Chui, Dirk Jan A R Moes, Stijn L W Koolen, et al.
British Journal of Clinical Pharmacology|June 25, 2010
Population pharmacokinetics of intravenously and orally administered docetaxel with or without co-administration of ritonavir in patients with advanced cancerStijn L W Koolen, Roos L Oostendorp, Jos H Beijnen, et al.
Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences|March 20, 2019
Quantification of afatinib, alectinib, crizotinib and osimertinib in human plasma by liquid chromatography/triple-quadrupole mass spectrometry; focusing on the stability of osimertinibG D Marijn Veerman, Mei H Lam, Ron H J Mathijssen, et al.
Journal of Pharmaceutical and Biomedical Analysis|November 29, 2017
Bioanalytical methods for the quantification of hydromorphone, fentanyl, norfentanyl, morphine, morphine-3ß-glucuronide and morphine-6ß-glucuronide in human plasmaPeter de Bruijn, Evelien J M Kuip, Mei-Ho Lam, et al.
Pageof 13

Showing results (1-10 of 125) with videos related to

Sort By:
Pageof 13
Cancers|August 12, 2022
Drug Repurposing, a Fast-Track Approach to Develop Effective Treatments for GlioblastomaIoannis Ntafoulis, Stijn L W Koolen, Sieger Leenstra, et al.
International Journal of Nanomedicine|November 2, 2020
Recent Clinical Developments of Nanomediated Drug Delivery Systems of Taxanes for the Treatment of CancerRuben A G van Eerden, Ron H J Mathijssen, Stijn L W Koolen
Drugs|March 14, 2024
Tamoxifen Dose De-Escalation: An Effective Strategy for Reducing Adverse Effects?Sanne M Buijs, Stijn L W Koolen, Ron H J Mathijssen, et al.
Cardiovascular Research|February 7, 2019
Vascular Cardio-Oncology: Vascular Endothelial Growth Factor inhibitors and hypertensionJorie Versmissen, Katrina M Mirabito Colafella, Stijn L W Koolen, et al.
Drugs|February 12, 2025
From Prospective Evaluation to Practice: Model-Informed Dose Optimization in OncologyBram C Agema, Birgit C P Koch, Ron H J Mathijssen, et al.
Pharmacology Research & Perspectives|July 26, 2024
Treatment of [99mTc]Tc-hydroxy-diphosphonate ([99mTc]Tc-HDP) extravasation using hyaluronidaseKevin R Doornhof, Quido de Lussanet de la Sablonière, Stijn L W Koolen, et al.
British Journal of Clinical Pharmacology|June 20, 2023
Pharmacokinetic profile of irinotecan in patients with chronic kidney disease: Two cases and literature reviewChang Yue Chui, Dirk Jan A R Moes, Stijn L W Koolen, et al.
British Journal of Clinical Pharmacology|June 25, 2010
Population pharmacokinetics of intravenously and orally administered docetaxel with or without co-administration of ritonavir in patients with advanced cancerStijn L W Koolen, Roos L Oostendorp, Jos H Beijnen, et al.
Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences|March 20, 2019
Quantification of afatinib, alectinib, crizotinib and osimertinib in human plasma by liquid chromatography/triple-quadrupole mass spectrometry; focusing on the stability of osimertinibG D Marijn Veerman, Mei H Lam, Ron H J Mathijssen, et al.
Journal of Pharmaceutical and Biomedical Analysis|November 29, 2017
Bioanalytical methods for the quantification of hydromorphone, fentanyl, norfentanyl, morphine, morphine-3ß-glucuronide and morphine-6ß-glucuronide in human plasmaPeter de Bruijn, Evelien J M Kuip, Mei-Ho Lam, et al.
Pageof 13